These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 7049383

  • 1. Progress in acute myelogenous leukemia.
    Gale RP.
    Cancer Treat Rep; 1981; 65 Suppl 4():87-92. PubMed ID: 7049383
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A, German AML Cooperative Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4496-504. PubMed ID: 14673036
    [Abstract] [Full Text] [Related]

  • 4. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
    Archimbaud E, Fiere D, Treille-Ritouet D, Adeleine P, Guyotat D, Sebban C, Vuvan H, Viala JJ.
    Cancer Treat Rep; 1987 Jun 15; 71(6):571-4. PubMed ID: 3555788
    [Abstract] [Full Text] [Related]

  • 5. Intensive chemotherapy for acute myelogenous leukemia.
    Gale RP, Foon KA, Cline MJ, Zighelboim J.
    Ann Intern Med; 1981 Jun 15; 94(6):753-7. PubMed ID: 6940466
    [Abstract] [Full Text] [Related]

  • 6. Two years' experience in the treatment of acute myeloid leukaemia using a three-drug regimen: daunorubicin, cytosine arabinoside and 6-thioguanine.
    McCann SR, Lawlor E, Kinsella IA, Temperley IJ.
    Ir Med J; 1982 Nov 15; 75(11):415-7. PubMed ID: 6959984
    [No Abstract] [Full Text] [Related]

  • 7. [Bone marrow transplantation in Mexico. Report of the 1st successful case in acute myeloblastic leukemia. Grupo de Trasplante Medular Oseo del INNSZ].
    León E, Sosa R.
    Rev Invest Clin; 1992 Nov 15; 44(3):383-6. PubMed ID: 1488582
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May 15; 18(3):192-8. PubMed ID: 4517790
    [No Abstract] [Full Text] [Related]

  • 10. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
    Hayat M, Jehn U, Willemze R, Haanen C, Zittoun R, Monconduit M, Lowenberg B, Stryckmans P, Peetermans M, De Cataldo F.
    Cancer; 1986 Aug 01; 58(3):617-23. PubMed ID: 3524789
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I, Hara M, Ohmoto E, Oda Y, Endo Y, Fujimoto S, Uchida K, Takaoka K, Watanabe S, Lai M, Kohi F, Kitajima K, Kimura I, Sanada H, Tokioka M, Adachi T, Yorimitsu S.
    Gan To Kagaku Ryoho; 1982 Sep 01; 9(9):1617-22. PubMed ID: 6964050
    [Abstract] [Full Text] [Related]

  • 15. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
    Rees JK, Gray RG, Swirsky D, Hayhoe FG.
    Lancet; 1986 Nov 29; 2(8518):1236-41. PubMed ID: 2878130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feasibility and efficacy of 5-azacytidine used early in the therapy of adult acute nonlymphocytic leukemia: an ECOG pilot study.
    Cassileth PA, Petrillo MH, Cooper RA, Katz ME.
    Cancer Clin Trials; 1979 Nov 29; 2(4):339-43. PubMed ID: 93983
    [Abstract] [Full Text] [Related]

  • 19. Successful re-induction therapy for acute myelogenous leukemia with cytosine arabinoside and daunorubicin.
    Stein RS, Flexner JM.
    Cancer Treat Rep; 1979 Nov 29; 63(11-12):2123-4. PubMed ID: 294309
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
    Sanz MA, Lorenzo JI, Sanz GF, Martín Aragonés G, Rafecas FJ, Martínez JA, Gomis F.
    Sangre (Barc); 1988 Dec 29; 33(6):497-504. PubMed ID: 3247626
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.